| Clopidogrel vs. Aspirin in Patients at Risk of Ischemic Events |
CAPRIE |
3 |
 |
| Secondary Prevention of Small Subcortical Strokes Trial |
SPS3 |
3 |
 |
| Management of ATherothrombosis with Clopidogrel in High-risk patients with recent TIA or ischemic stroke |
MATCH |
N/A |
|
| Aortic Arch Related Cerebral Hazard Trial (ARCH) |
ARCH |
3 |
 |
| RESPECT PFO Clinical Trial |
|
2 |
|
| Fast Assessment of Stroke and Transient ischemic attack to prevent Early Recurrence - Pilot Study |
FASTER |
N/A |
|
| Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis |
CARESS |
N/A |
|
| PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes |
|
4 |
|
| Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA) |
|
3 |
|
| Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1) |
COGENT-1 |
3 |
 |
| Clopidogrel and Aspirin versus Aspirin Alone in Stroke Patients |
PLUTO |
N/A |
|
| COMbination of Clopidogrel and Aspirin for Prevention of Early REcurrence in Acute Atherothrombotic Stroke |
COMPRESS |
4 |
|
| Amplified Benefit of Clopidogrel Versus Aspirin in Patients With Diabetes Mellitus |
|
N/A |
|
| Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE W) |
|
3 |
|
| Drug-Eluting Stents for the Treatment of Intracranial Atherosclerosis. |
|
N/A |
|
| Trial of Cilostazol in Symptomatic Intracranial Arterial Stenosis II |
TOSS-2 |
4 |
|
| A Comparison of Prasugrel (CS-747) and Clopidogrel in Acute Coronary Syndrome Subjects Who Are to Undergo Percutaneous Coronary Intervention |
|
3 |
|
| Long Term Open Follow-up With H376/95 vs. Warfarin |
|
2 |
|
| The Comparison of Effects Between Increased Dose of Clopidogrel and Addition of Cilostazol |
4C-DES |
N/A |
|
| The Austrian Paradoxical Cerebral Embolism Trial
|
TACET |
N/A |
|
| Wingspan Stenting for Symptomatic Severe Stenosis of Intracranial Atherosclerosis Registry in China |
WingspanSSIR |
N/A |
|
| Stent-assisted Angioplasty of the Offending Intracranial Stenosis plus Optimal Medical Therapy versus Optimal Medical Therapy Alone
|
ASSIST II |
N/A |
|
| A Study of the Onset and Offset of Antiplatelet Effects Comparing Ticagrelor, Clopidogrel, and Placebo With Aspirin |
|
2 |
|
| Clopidogrel of loading dosage to treat acute ischaemic stroke in China |
CLASS-CHINA |
N/A |
 |
| Dual antiplatelet therapy in the acute phase following stroke and transient ischaemic attack (TIA): which is the best regimen? |
AMBDAP |
N/A |
|
| Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke |
TARDIS |
N/A |
|
| Vertebral Artery Stenting Trial |
VAST |
N/A |
|
| A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary Syndrome |
PLATO |
3 |
|
| Cervical Artery Dissection In Stroke Study: Feasibility Phase. |
CADISS |
N/A |
|
| Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A) |
|
3 |
|
| Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial |
POINT |
3 |
|
| Standard Medical Management in Secondary Prevention of Ischemic Stroke in China |
SMART |
N/A |
|
| Fast Assessment of Stroke and Transient Ischemic Attack to Prevent Early Recurrence (FASTER) |
|
2/3 |
|
| Clopidogrel in High-risk Patients With Acute Non-disabling Cerebrovascular Events |
CHANCE |
3 |
|
| CoMparison of TriflusAl and Clopidogrel Effect in Secondary Prevention of STroke Based on the CytochRome P450 2C19 GenOtyping |
MAESTRO |
4 |
|
| The Inhibition of Platelet Antiaggregating Activity of Clopidogrel by Atorvastatin Detected by Erythromycin Breath Test: a Metabolic Inhibition of Hepatic Cytochrome P450-3A |
|
N/A |
|
